Skip to main content

Table 4 Resistance rate of major gram-negative bacilli to commonly used drugs(%)

From: Pathogens distribution and drug resistance in patients with acute cerebral infarction complicated with diabetes and nosocomial pulmonary infection

Name of drug Diabetic group Non-diabetic group
Imipenem 38.4 25.9
Piperacillin and Sulbactam 68.2 55.9
Piperacillin and Tazobactam 49.7 59.6
ceftazidime 82.5 54.6
ceftriaxone 91.7 78.9
Ciprofloxacin 95.6 66.1
amikacin 50.8 42.7
Trimethoprim/sulfonamide 85.6 64.1
gentamicin 83.3 70.3
levofloxacin 61.6 50.8
tobramycin 44 28.6
drug-resistance rates 68.3 54.3